Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 306

1.

Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.

Shibata Y, Nakatsuka A, Eguchi J, Miyamoto S, Masuda Y, Awazawa M, Takaki A, Yoshida R, Yagi T, Wada J.

J Med Case Rep. 2018 Dec 14;12(1):368. doi: 10.1186/s13256-018-1901-y.

2.

Non-alcoholic fatty liver disease in patients with autoimmune hepatitis.

Takahashi A, Arinaga-Hino T, Ohira H, Abe K, Torimura T, Zeniya M, Abe M, Yoshizawa K, Takaki A, Suzuki Y, Kang JH, Nakamoto N, Fujisawa T, Tanaka A, Takikawa H; Japan AIH Study Group (JAIHSG).

JGH Open. 2018 Mar 30;2(2):54-58. doi: 10.1002/jgh3.12046. eCollection 2018 Apr.

3.

Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.

Aono A, Morimoto K, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.

J Infect Chemother. 2018 Nov 14. pii: S1341-321X(18)30420-3. doi: 10.1016/j.jiac.2018.10.010. [Epub ahead of print]

PMID:
30447882
4.

Monitoring serum proangiogenic cytokines from hepatocellular carcinoma patients treated with sorafenib.

Adachi T, Nouso K, Miyahara K, Oyama A, Wada N, Dohi C, Takeuchi Y, Yasunaka T, Onishi H, Ikeda F, Nakamura S, Shiraha H, Takaki A, Takabatake H, Fujioka SI, Kobashi H, Takuma Y, Iwadou S, Uematsu S, Takaguchi K, Hagihara H, Okada H; Okayama Liver Cancer Group.

J Gastroenterol Hepatol. 2018 Nov 6. doi: 10.1111/jgh.14535. [Epub ahead of print]

PMID:
30402928
5.

A simplified pyrazinamidase test for pyrazinamide drug susceptibility in Mycobacterium tuberculosis.

Aono A, Chikamatsu K, Yamada H, Igarashi Y, Murase Y, Takaki A, Mitarai S.

J Microbiol Methods. 2018 Nov;154:52-54. doi: 10.1016/j.mimet.2018.09.018. Epub 2018 Oct 11.

PMID:
30316980
6.

Health-related quality of life in patients with autoimmune hepatitis: A questionnaire survey.

Takahashi A, Moriya K, Ohira H, Arinaga-Hino T, Zeniya M, Torimura T, Abe M, Takaki A, Kang JH, Inui A, Fujisawa T, Yoshizawa K, Suzuki Y, Nakamoto N, Koike K, Yoshiji H, Goto A, Tanaka A, Younossi ZM, Takikawa H; Japan AIH Study Group.

PLoS One. 2018 Oct 4;13(10):e0204772. doi: 10.1371/journal.pone.0204772. eCollection 2018.

7.

Mycolicibacterium smegmatis, Basonym Mycobacterium smegmatis, Expresses Morphological Phenotypes Much More Similar to Escherichia coli Than Mycobacterium tuberculosis in Quantitative Structome Analysis and CryoTEM Examination.

Yamada H, Yamaguchi M, Igarashi Y, Chikamatsu K, Aono A, Murase Y, Morishige Y, Takaki A, Chibana H, Mitarai S.

Front Microbiol. 2018 Sep 11;9:1992. doi: 10.3389/fmicb.2018.01992. eCollection 2018.

8.

Six species of nontuberculous mycobacteria carry non-identical 16S rRNA gene copies.

Takeda K, Chikamatsu K, Igarashi Y, Morishige Y, Murase Y, Aono A, Yamada H, Takaki A, Mitarai S.

J Microbiol Methods. 2018 Dec;155:34-36. doi: 10.1016/j.mimet.2018.08.012. Epub 2018 Aug 27.

PMID:
30165088
9.

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy.

Wada N, Ikeda F, Mori C, Takaguchi K, Fujioka SI, Kobashi H, Morimoto Y, Kariyama K, Sakaguchi K, Hashimoto N, Moriya A, Kawaguchi M, Miyatake H, Hagihara H, Kubota J, Takayama H, Takeuchi Y, Yasunaka T, Takaki A, Iwasaki Y, Okada H.

Acta Med Okayama. 2018 Aug;72(4):401-406. doi: 10.18926/AMO/56178.

10.

Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis.

Yagi M, Tanaka A, Abe M, Namisaki T, Yoshiji H, Takahashi A, Ohira H, Komori A, Yamagiwa S, Kikuchi K, Yasunaka T, Takaki A, Ueno Y, Honda A, Matsuzaki Y, Takikawa H.

Sci Rep. 2018 Aug 22;8(1):12542. doi: 10.1038/s41598-018-31063-8.

11.

Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation.

Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, Takaki A, Iwanaga K, Nishimura N, Fuji S, Fukuda T, Nosaka K, Matsuoka M.

Bone Marrow Transplant. 2018 Aug 16. doi: 10.1038/s41409-018-0291-5. [Epub ahead of print] No abstract available.

PMID:
30116017
12.

Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease.

Uchida D, Takaki A, Adachi T, Okada H.

Nutrients. 2018 Jul 27;10(8). pii: E977. doi: 10.3390/nu10080977. Review.

13.

Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease.

Kamiya Y, Ota S, Tanaka Y, Yamashita K, Takaki A, Ito S.

Asia Ocean J Nucl Med Biol. 2018 Spring;6(2):129-138. doi: 10.22038/aojnmb.2018.10595.

14.

Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom.

Morimoto K, Aono A, Murase Y, Sekizuka T, Kurashima A, Takaki A, Sasaki Y, Igarashi Y, Chikamatsu K, Goto H, Yamada H, Kuroda M, Mitarai S.

ERJ Open Res. 2018 Jul 3;4(3). pii: 00150-2017. doi: 10.1183/23120541.00150-2017. eCollection 2018 Jul.

15.

First case of sexually transmitted asymptomatic female genital tuberculosis from spousal epididymal tuberculosis diagnosed by active screening.

Kimura M, Araoka H, Baba H, Okada C, Murase Y, Takaki A, Mitarai S, Yoneyama A.

Int J Infect Dis. 2018 Aug;73:60-62. doi: 10.1016/j.ijid.2018.05.021. Epub 2018 Jun 4.

16.

Successful treatment by pembrolizumab in a patient with end-stage renal disease with advanced non-small cell lung cancer and high PD-L1 expression.

Ishizuka S, Sakata S, Yoshida C, Takaki A, Saeki S, Nakamura K, Fujii K.

Respir Investig. 2018 Jul;56(4):361-364. doi: 10.1016/j.resinv.2018.03.005. Epub 2018 May 10.

PMID:
29764752
17.

A subclinical high tricuspid regurgitation pressure gradient independent of the mean pulmonary artery pressure is a risk factor for the survival after living donor liver transplantation.

Saragai Y, Takaki A, Umeda Y, Matsusaki T, Yasunaka T, Oyama A, Kaku R, Nakamura K, Yoshida R, Nobuoka D, Kuise T, Takagi K, Adachi T, Wada N, Takeuchi Y, Koike K, Ikeda F, Onishi H, Shiraha H, Nakamura S, Morimatsu H, Ito H, Fujiwara T, Yagi T, Okada H.

BMC Gastroenterol. 2018 May 15;18(1):62. doi: 10.1186/s12876-018-0793-z.

18.

New Left Lobe Transplantation Procedure with Caval Reconstruction Using an Inverted Composite Graft for Chronic Budd-Chiari Syndrome in Living-Donor Liver Transplantation-A Case Report.

Yagi T, Takagi K, Yoshida R, Umeda Y, Nobuoka D, Kuise T, Fujiwara T, Takaki A.

Transplant Proc. 2018 May;50(4):1192-1195. doi: 10.1016/j.transproceed.2017.11.078.

19.

Risk Analysis for Invasive Fungal Infection after Living Donor Liver Transplantation: Which Patient Needs Potent Prophylaxis?

Utsumi M, Umeda Y, Yagi T, Nagasaka T, Shinoura S, Yoshida R, Nobuoka D, Kuise T, Fuji T, Takagi K, Takaki A, Fujiwara T.

Dig Surg. 2019;36(1):59-66. doi: 10.1159/000486548. Epub 2018 Apr 12.

PMID:
29649828
20.

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

Sakata S, Matsuoka Y, Kawahara K, Kakiuchi Y, Takaki A, Hirosue A, Yoshida R, Saeki S, Fujii K, Nakayama H.

Respir Investig. 2018 Mar;56(2):195-198. doi: 10.1016/j.resinv.2017.11.006. Epub 2017 Dec 21.

PMID:
29548660

Supplemental Content

Loading ...
Support Center